Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
DXCM [NASD]
DexCom, Inc.
Index- P/E- EPS (ttm)-0.37 Insider Own2.60% Shs Outstand75.48M Perf Week3.87%
Market Cap3.36B Forward P/E618.06 EPS next Y0.07 Insider Trans-11.54% Shs Float73.83M Perf Month11.28%
Income-27.10M PEG- EPS next Q-0.06 Inst Own98.40% Short Float6.40% Perf Quarter18.10%
Sales200.50M P/S16.75 EPS this Y46.80% Inst Trans0.73% Short Ratio7.37 Perf Half Y35.88%
Book/sh1.33 P/B33.46 EPS next Y121.90% ROA-21.80% Target Price44.27 Perf Year48.73%
Cash/sh0.81 P/C54.79 EPS next 5Y32.50% ROE-31.10% 52W Range27.10 - 49.83 Perf YTD25.67%
Dividend- P/FCF- EPS past 5Y26.80% ROI-31.80% 52W High-10.70% Beta0.39
Dividend %- Quick Ratio2.60 Sales past 5Y74.80% Gross Margin65.50% 52W Low64.21% ATR1.56
Employees646 Current Ratio3.00 Sales Q/Q64.20% Oper. Margin-13.10% RSI (14)58.58 Volatility2.73% 4.03%
OptionableYes Debt/Eq0.06 EPS Q/Q42.90% Profit Margin-13.50% Rel Volume0.86 Prev Close44.50
ShortableYes LT Debt/Eq0.04 EarningsNov 06 AMC Payout- Avg Volume640.85K Price44.50
Recom2.10 SMA205.82% SMA505.10% SMA20012.26% Volume0 Change0.00%
07-Aug-14Reiterated Canaccord Genuity Buy $40 → $48
17-Jun-14Reiterated Canaccord Genuity Buy $38 → $40
24-Jan-14Resumed Canaccord Genuity Buy $34 → $44
14-Jan-14Reiterated The Benchmark Company Buy $40 → $44
07-Nov-13Upgrade Northland Capital Under Perform → Market Perform
15-Oct-13Initiated The Benchmark Company Buy $37
12-Aug-13Reiterated Feltl & Co. Sell $16.50 → $18.25
08-Aug-13Reiterated Canaccord Genuity Buy $25 → $26
24-Jul-13Downgrade Northland Capital Outperform → Under Perform $17
13-Jun-13Downgrade Feltl & Co. Hold → Sell
10-Jun-13Downgrade Wunderlich Buy → Hold $20
13-Mar-13Reiterated Wunderlich Buy $18 → $20
25-Feb-13Reiterated Feltl & Co. Hold $14 → $15.50
14-Jan-13Reiterated Wunderlich Buy $15 → $18
18-Oct-12Initiated Northland Securities Market Perform $12
17-Jan-12Initiated Brean Murray Buy $12.50
11-Jan-12Downgrade MLV & Co Buy → Hold $9
29-Dec-11Initiated Wunderlich Buy $12
20-Dec-11Initiated MLV & Co Buy $11
28-Oct-11Downgrade Feltl & Co. Buy → Hold
30-Oct-14 08:30AM  DexCom Announces Upcoming Conference Presentations Business Wire
23-Oct-14 08:30AM  DexCom Schedules Third Quarter 2014 Earnings Release and Conference Call for November 6, 2014 at 4:30 p.m. Eastern Time Business Wire
20-Oct-14 02:19PM  [$$] Dexcom's Remote Glucose-Monitoring Device Cleared at The Wall Street Journal
09:24AM  FDA Approves Dexcom SHARE, the First Remote Mobile Communications Device Used for Continuous Glucose Monitoring (CGM) Business Wire
06-Oct-14 05:03PM  DEXCOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
27-Sep-14 12:06AM  [$$] Citizen Hackers Tinker With Medical Devices at The Wall Street Journal
26-Sep-14 07:19PM  [$$] Citizen Hackers Tinker With Medical Devices at The Wall Street Journal
05:31PM  [video] Citizen Hackers Modify Diabetes Device at MarketWatch
03-Sep-14 01:04PM  3 Stocks Dragging The Health Services Industry Downward at TheStreet
11:15AM  Insider Trading Alert - NATI, DXCM And CNC Traded By Insiders at TheStreet
25-Aug-14 05:50PM  [video] A sensor to swallow with your medicine at CNBC
22-Aug-14 04:05PM  Top Insider Sells Highlight: Dexcom Inc. Gurufocus
21-Aug-14 01:04PM  DXCM, HOLX And CYH, Pushing Health Services Industry Downward at TheStreet
14-Aug-14 12:00PM  DexCom Continues to Gain; Enters Data Integration Deal Zacks
13-Aug-14 01:04PM  DEXCOM INC Financials EDGAR Online Financials
07-Aug-14 11:10AM  DexCom Sees Narrower Q2 Loss; Revenues Top Estimates Zacks +13.61%
09:47AM  Trade-Ideas: DexCom (DXCM) Is Today's "Barbarian At The Gate" Stock at TheStreet
08:30AM  Dexcom Announces Data Integration Relationship with Asante Solutions, Makers of the Snap Insulin Pump Business Wire
06-Aug-14 04:30PM  DexCom Inc Earnings Call scheduled for 4:30 pm ET today CCBN
04:06PM  DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:01PM  DexCom, Inc. Reports Second Quarter 2014 Financial Results Business Wire
07:07AM  Q2 2014 DEXCOM INC Earnings Release - After Market Close CCBN
05-Aug-14 04:05PM  Insulet and Dexcom Agree to Develop a CGM-Integrated Personal Diabetes Manager Marketwired
01-Aug-14 12:05PM  Jay D. Miller, the President and CEO of IMRIS Inc. (IMRS), Interviews with The Wall Street Transcript Wall Street Transcript
31-Jul-14 08:30AM  DexCom to Present at Canaccord Genuity 34th Annual Growth Conference Business Wire -6.06%
06:00AM  'Mad Money' Lightning Round: Stay With Thermo Fisher Scientific at TheStreet
23-Jul-14 08:30AM  DexCom Schedules Second Quarter 2014 Earnings Release and Conference Call for August 6, 2014 at 4:30 p.m. Eastern Time Business Wire
18-Jul-14 01:10PM  5 New Medical Technologies For Diabetics Benzinga
07-Jul-14 08:30AM  DEXCOM INC Files SEC form 8-K, Entry into a Material Definitive Agreement EDGAR Online
16-Jun-14 02:30PM  DexCom Collaborates with Insulet Corporation Zacks +5.08%
12:00AM  Freedom for Diabetics as Bionic Pancreas Passes Testing at Bloomberg
15-Jun-14 09:00PM  Diabetics Get Freedom in Bionic Pancreas Real-World Trial at Bloomberg
13-Jun-14 04:01PM  DexComs Forthcoming Mobile App Platform to Integrate Data from Insulets OmniPod System Business Wire
05-Jun-14 09:17AM  Top Swing Trade Ideas for Thursday, June 5: DexCom, Conn's and More at TheStreet
04-Jun-14 05:15PM  [video] Health app space heats up at CNBC +7.06%
12:50PM  FDA Nod for DexCom's G4 PLATINUM System Zacks
08:30AM  DEXCOM INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders EDGAR Online
03-Jun-14 04:01PM  The first and only real-time professional CGM, the Dexcom G4® PLATINUM Professional Continuous Glucose Monitoring System (CGM) Receives FDA Approval Business Wire
27-May-14 08:30AM  DexCom Announces Upcoming Conference Presentations Business Wire
16-May-14 03:55PM  Why Jim Cramer Says Investors Should Watch DexCom (DXCM) Stock at TheStreet
11:45AM  [video] Jim Cramer on Why DexCom Could be a Good Portfolio Addition at TheStreet
11:37AM  The Bellwether We've Searched For at TheStreet
12-May-14 10:27AM  DexCom has a conference call hosted by JPMorgan at theflyonthewall.com
06-May-14 08:32AM  DexCom Misses, Sees Broader Q1 Loss Zacks
02-May-14 02:11PM  Why DexCom Inc. Shares Briefly Swooned at Motley Fool
01-May-14 08:55PM  DexCom's CEO Discusses Q1 2014 Results - Earnings Call Transcript at Seeking Alpha
04:30PM  DEXCOM INC Earnings Call scheduled for 4:30 pm ET today CCBN
04:25PM  DexCom, Inc. Discusses Q1 2014 Results (Webcast) at Seeking Alpha
04:09PM  DEXCOM INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits EDGAR Online
04:01PM  DexCom, Inc. Reports First Quarter 2014 Financial Results Business Wire
07:07AM  Q1 2014 DEXCOM INC Earnings Release - After Market Close CCBN
30-Apr-14 03:37PM  5 stocks to watch at MarketWatch
08:30AM  DexCom Announces Upcoming Conference Presentations Business Wire
24-Apr-14 08:30AM  DexCom Schedules First Quarter 2014 Earnings Release and Conference Call for May 1, 2014 at 4:30 p.m. Eastern Time Business Wire
16-Apr-14 01:09PM  1 Stock Helping Revolutionize Diabetes Monitoring at Motley Fool +5.47%
15-Apr-14 06:46PM  Lightning Round: Delta, LinkedIn & More at CNBC
10-Apr-14 01:50PM  Delcath Systems Shares Tank on Stock Split Zacks -5.83%
09:50AM  Why DexCom (DXCM) Stock Is Higher Today at TheStreet
08:10AM  Top Analyst Upgrades and Downgrades: Apple, EMC, Facebook, Twitter, IBM , AcelRx and More at 24/7 Wall St.
08:10AM  Top Analyst Upgrades and Downgrades: Apple, EMC, Facebook, Twitter, IBM , AcelRx and More 24/7 Wall St.
05:54AM  DexCom upgraded to Buy from Neutral at Sterne Agee theflyonthewall.com
08-Apr-14 07:56AM  DexCom (DXCM) is now in Oversold Territory Zacks
03-Apr-14 02:30PM  DexCom Shares Fall on FDA Warning Zacks
01-Apr-14 01:50PM  Balanced View on Haemonetics Zacks
31-Mar-14 01:50PM  Balanced View on Hologic Zacks
25-Mar-14 04:02PM  Should You Buy DexCom After The Meteoric Rise? at Seeking Alpha
09:32AM  [$$] Suicide Banker Feared Investigation at The Wall Street Journal
08:30AM  DexCom Receives FDA Warning Letter for Administrative Deficiencies in its MDR Reporting Business Wire
24-Mar-14 07:12AM  Why DexCom (DXCM) Could Be a Potential Winner Zacks
05-Mar-14 04:04PM  Dexcom Supports NASCAR Driver Ryan Reeds American Diabetes Association Drive to Stop Diabetes Initiative Business Wire
04-Mar-14 06:23AM  Is DexCom (DXCM) a Great Growth Stock? Zacks
28-Feb-14 11:45AM  Insider Trading Alert - WAB, DXCM And CMCSA Traded By Insiders at TheStreet
25-Feb-14 08:40AM  DexCom Beats, Sees Narrower Q4 Loss Zacks
08:30AM  DexCom Announces Upcoming Conference Presentations Business Wire
21-Feb-14 07:54AM  DexCom price target raised to $50 from $45 at Stephens at theflyonthewall.com
20-Feb-14 08:56PM  DexCom's CEO Discusses Q4 2013 Results - Earnings Call Transcript Optionetics
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems. It offers its systems for ambulatory use by people with diabetes; and for use by healthcare providers in the hospital for the treatment of patients with and without diabetes. The company's ambulatory product line includes SEVEN PLUS, DexCom G4 system, and DexCom G4 PLATINUM system for adults with diabetes to detect trends and track glucose patterns, to aid in the detection of hypoglycemia and hyperglycemia, and to facilitate acute and long-term therapy adjustments, as well as DexCom SHARE, a remote monitoring system, which provides secondary notification and does not replace real time continuous glucose monitoring or standard home blood glucose monitoring. Its in-hospital product line comprises GlucoClear, a blood-based in-vivo automated glucose monitoring system for use by healthcare providers in the hospital. The company also offers SweetSpot, a software platform that enables patients to aggregate and analyze data from diabetes devices and to share it with their healthcare providers. It markets its products directly to endocrinologists, physicians, and diabetes educators primarily in the United States. The company was founded in 1999 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Balo Andrew KSVP, Regulatory and ClinicalOct 27Option Exercise7.6310,00076,300160,130Oct 28 08:27 PM
Balo Andrew KSVP, Regulatory and ClinicalOct 27Sale42.9810,000429,755150,130Oct 28 08:27 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesOct 23Option Exercise6.034,00024,120123,950Oct 24 05:13 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesOct 23Sale43.584,000174,310119,950Oct 24 05:13 PM
ROPER JESSVP, CFOOct 20Option Exercise7.638,00061,04091,342Oct 21 07:53 PM
ROPER JESSVP, CFOOct 20Sale41.188,000329,46383,342Oct 21 07:53 PM
GREGG TERRANCE HCEOOct 15Option Exercise6.8525,000171,250420,626Oct 16 08:02 PM
GREGG TERRANCE HCEOOct 15Sale39.6325,000990,693395,626Oct 16 08:02 PM
GREGG TERRANCE HCEOOct 15Sale39.6310,000396,277620,389Oct 16 08:02 PM
LISTER JOHNSr. VP, General CounselOct 13Option Exercise4.581,7508,015112,075Oct 14 06:21 PM
LISTER JOHNSr. VP, General CounselOct 13Sale40.413,400137,405108,675Oct 14 06:21 PM
VALDES JORGE ACTOOct 08Option Exercise7.2516,000116,000134,748Oct 10 05:09 PM
VALDES JORGE ACTOOct 08Sale40.2916,000644,651118,748Oct 10 05:09 PM
Balo Andrew KSVP, Regulatory and ClinicalSep 25Option Exercise7.6310,00076,300160,130Sep 25 08:30 PM
Balo Andrew KSVP, Regulatory and ClinicalSep 25Sale40.7110,000407,072150,130Sep 25 08:30 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 23Option Exercise7.6314,000106,820242,866Sep 24 06:42 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesSep 23Option Exercise6.034,00024,120123,950Sep 24 06:43 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Sep 23Sale40.3214,000564,483228,866Sep 24 06:42 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesSep 23Sale40.324,000161,262119,950Sep 24 06:43 PM
ROPER JESSVP, CFOSep 18Option Exercise7.688,00061,44088,842Sep 18 06:38 PM
ROPER JESSVP, CFOSep 18Sale41.918,000335,30683,342Sep 18 06:38 PM
LISTER JOHNSr. VP, General CounselSep 15Option Exercise4.585,50025,190110,325Sep 15 08:57 PM
GREGG TERRANCE HCEOSep 15Option Exercise6.8525,000171,250420,626Sep 17 06:59 PM
GREGG TERRANCE HCEOSep 15Sale41.1425,0001,028,555395,626Sep 17 06:59 PM
GREGG TERRANCE HCEOSep 15Sale41.1410,000411,422630,389Sep 17 06:59 PM
LISTER JOHNSr. VP, General CounselSep 12Option Exercise4.581,7508,015106,575Sep 15 08:57 PM
LISTER JOHNSr. VP, General CounselSep 12Sale43.703,518153,739104,825Sep 15 08:57 PM
Balo Andrew KSVP, Regulatory and ClinicalSep 11Option Exercise7.6310,00076,300164,116Sep 12 08:02 PM
Balo Andrew KSVP, Regulatory and ClinicalSep 11Sale42.9710,000429,706154,534Sep 12 08:02 PM
VALDES JORGE ACTOSep 08Option Exercise3.1916,00051,040158,621Sep 10 07:42 PM
VALDES JORGE ACTOSep 08Sale42.9816,000687,736142,621Sep 10 07:42 PM
KAHN BARBARADirectorAug 28Sale44.524,000178,09249,525Sep 02 06:15 PM
LORD JONATHAN T MDDirectorAug 26Option Exercise7.7820,000155,600157,107Aug 28 05:32 PM
MOY JEFFREYSVP, OperationsAug 26Option Exercise8.4116,663140,177107,916Aug 28 05:32 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 26Option Exercise20.6516,000330,400257,399Aug 27 05:57 PM
GREGG TERRANCE HCEOAug 26Sale46.055,000230,267640,389Aug 28 05:31 PM
LORD JONATHAN T MDDirectorAug 26Sale45.5620,000911,240137,107Aug 28 05:32 PM
MOY JEFFREYSVP, OperationsAug 26Sale45.3016,663754,83597,916Aug 28 05:32 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 26Sale44.8516,000717,523241,399Aug 27 05:57 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 25Option Exercise7.6314,000106,820255,399Aug 27 05:57 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 25Option Exercise7.6310,00076,300169,205Aug 27 05:59 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesAug 25Option Exercise6.034,00024,120130,582Aug 27 05:58 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Aug 25Sale44.2414,000619,338241,399Aug 27 05:57 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 25Sale44.1210,000441,243159,205Aug 27 05:59 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesAug 25Sale44.354,000177,406126,582Aug 27 05:58 PM
GREGG TERRANCE HCEOAug 22Option Exercise6.856,10741,833401,733Aug 25 05:14 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 22Option Exercise3.1920,00063,800179,205Aug 25 05:13 PM
GREGG TERRANCE HCEOAug 22Sale44.586,107272,242395,626Aug 25 05:14 PM
GREGG TERRANCE HCEOAug 22Sale44.367,500332,672645,389Aug 25 05:14 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 22Sale44.2420,000884,722159,205Aug 25 05:13 PM
KAHN BARBARADirectorAug 21Sale43.422,20095,52453,525Aug 21 07:49 PM
VALDES JORGE ACTOAug 21Sale43.5810,671465,04064,195Aug 25 05:15 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesAug 19Option Exercise9.8020,000196,000146,582Aug 20 08:08 PM
GREGG TERRANCE HCEOAug 19Option Exercise5.6775,000424,950430,626Aug 20 08:11 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesAug 19Sale45.0120,000900,278126,582Aug 20 08:08 PM
GREGG TERRANCE HCEOAug 19Sale45.0875,0003,380,782395,626Aug 20 08:11 PM
GREGG TERRANCE HCEOAug 18Option Exercise7.0565,000458,450420,626Aug 20 08:11 PM
GREGG TERRANCE HCEOAug 18Sale44.1665,0002,870,580395,626Aug 20 08:11 PM
GREGG TERRANCE HCEOAug 18Sale44.0410,000440,448652,889Aug 20 08:11 PM
GREGG TERRANCE HCEOAug 15Option Exercise6.855,00034,250400,626Aug 19 06:25 PM
GREGG TERRANCE HCEOAug 15Sale44.065,000220,291395,626Aug 19 06:25 PM
GREGG TERRANCE HCEOAug 14Option Exercise7.2725,000181,750415,626Aug 15 05:13 PM
GREGG TERRANCE HCEOAug 14Sale44.2425,0001,105,944395,626Aug 15 05:13 PM
GREGG TERRANCE HCEOAug 13Option Exercise6.5838,607254,112411,734Aug 14 06:52 PM
GREGG TERRANCE HCEOAug 13Sale43.7938,6071,690,527395,626Aug 14 06:52 PM
LISTER JOHNSr. VP, General CounselAug 12Option Exercise4.581,7508,015114,305Aug 14 06:51 PM
GREGG TERRANCE HCEOAug 12Option Exercise8.9517,500156,625413,126Aug 14 06:52 PM
LISTER JOHNSr. VP, General CounselAug 12Sale43.683,353146,455112,555Aug 14 06:51 PM
GREGG TERRANCE HCEOAug 12Sale43.0917,500754,056395,626Aug 14 06:52 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 11Option Exercise8.9410,00089,400169,205Aug 12 05:44 PM
SAYER KEVIN RPresident & COOAug 11Sale43.8220,000876,492424,924Aug 15 05:12 PM
Balo Andrew KSVP, Regulatory and ClinicalAug 11Sale44.2410,000442,373159,205Aug 12 05:44 PM
VALDES JORGE ACTOAug 08Option Exercise3.1916,00051,040233,487Aug 12 05:45 PM
VALDES JORGE ACTOAug 08Sale43.5616,000697,006217,487Aug 12 05:45 PM
Balo Andrew KSVP, Regulatory and ClinicalJul 25Option Exercise8.9410,00089,400169,099Jul 29 07:07 PM
Balo Andrew KSVP, Regulatory and ClinicalJul 25Sale38.1910,000381,857159,099Jul 29 07:07 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jul 23Option Exercise7.6314,000106,820255,399Jul 24 05:49 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesJul 23Option Exercise6.034,00024,120129,887Jul 24 05:50 PM
Pacelli Steven RobertEVP, Strategy & Corp. Dev.Jul 23Sale38.2814,000535,986241,399Jul 24 05:49 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesJul 23Sale38.164,000152,654126,136Jul 24 05:50 PM
ROPER JESSVP, CFOJul 18Option Exercise7.798,00062,32095,786Jul 22 06:54 PM
ROPER JESSVP, CFOJul 18Sale36.018,000288,07087,786Jul 22 06:54 PM
Balo Andrew KSVP, Regulatory and ClinicalJul 11Option Exercise8.9410,00089,400169,099Jul 15 06:45 PM
Balo Andrew KSVP, Regulatory and ClinicalJul 11Sale35.9310,000359,347159,099Jul 15 06:45 PM
VALDES JORGE ACTOJul 08Option Exercise3.1916,00051,040233,487Jul 09 06:49 PM
VALDES JORGE ACTOJul 08Sale36.6616,000586,506217,487Jul 09 06:49 PM
Balo Andrew KSVP, Regulatory and ClinicalJun 25Option Exercise8.9410,00089,400169,099Jun 25 08:35 PM
Balo Andrew KSVP, Regulatory and ClinicalJun 25Sale40.6010,000405,982159,099Jun 25 08:35 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesJun 23Option Exercise6.034,00024,120130,136Jun 25 08:34 PM
DOUBLEDAY RICHARDSr. VP. Worldwide SalesJun 23Sale40.984,000163,925126,136Jun 25 08:34 PM
SKYLER JAY SDirectorJun 20Sale40.0030,0001,200,000145,884Jun 23 06:10 PM
SKYLER JAY SDirectorJun 19Sale40.0030,0001,200,000175,884Jun 23 06:10 PM
ROPER JESSVP, CFOJun 18Option Exercise7.698,00061,51094,286Jun 18 07:10 PM
ROPER JESSVP, CFOJun 18Sale39.178,000313,33387,786Jun 18 07:10 PM
GREGG TERRANCE HCEOJun 16Option Exercise6.8525,000171,250420,626Jun 18 07:11 PM
GREGG TERRANCE HCEOJun 16Sale37.2325,000930,800395,626Jun 18 07:11 PM
GREGG TERRANCE HCEOJun 16Sale37.2310,000372,320672,889Jun 18 07:11 PM
LISTER JOHNSr. VP, General CounselJun 12Option Exercise4.581,7508,015117,658Jun 13 05:01 PM
LISTER JOHNSr. VP, General CounselJun 12Sale36.133,500126,455115,908Jun 13 05:01 PM
Balo Andrew KSVP, Regulatory and ClinicalJun 11Option Exercise8.9410,00089,400166,483Jun 13 04:58 PM